
iBio, Inc. (NYSEA: IBIO), shares drowned in the Premarket following offering of its common stock
Today, In the premarket session, iBio, Inc. (NYSEA: IBIO), the stock dropped -10% to $1.35 after a biotechnology innovator, and biologics compounder announced today that